CAPOBIANCO, Marco

CAPOBIANCO, Marco  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.013 secondi).
Titolo Data di pubblicazione Autore(i) File
A Real-Life Study of Alemtuzumab: Impact of Previous Therapies and Washout Period on Disease Activity 2018 Sacca, F; Sormani, MP; Signori, A; Lanzillo, R; Baroncini, D; Annovazzi, P; Signoriello, E; Laroni, A; Capobianco, M; Sartori, A; La Gioia, S; Maniscalco, GT; Cordioli, C; Rasia, S; Clerico, M; Fenu, G; Cocco, E; Frau, J
A real-world study of Alemtuzumab in a cohort of Italian patients 2019 Sacca, F; Russo, CV; Frau, J; Annovazzi, P; Signoriello, E; Bonavita, S; Grasso, R; Clerico, M; Cordioli, C; Laroni, A; Capobianco, M; Clerici, VT; Sartori, A; Cavalla, P; Maniscalco, GT; La Gioia, S; Caleri, F; Giugno, A; Iodice, R; Carotenuto, A; Cocco, E; Fenu, G; Zaffaroni, M; Baronicini, D; Lus, G; Gallo, A; De Mercanti, SF; Lapucci, C; Di Francescantonio, V; Sormani, MP; Signori, A
Mitoxantrone-related acute myeloid leukaemia, induced one year after the discontinuation of mitoxantrone therapy 2006 Capobianco, M; Malucchi, S; Bosa, M; Fava, C; Avonto, L; Bertolotto, A
MS Italian patients manifesting natalizumab-related PML between 2009 and 2014. Report of the Italian group for MS-PML study 2015 De Rossi, N; Cordioli, C; Gerevini, S; Amato, MP; Bandini, F; Cavalla, P; Clerico, M; Capobianco, M; Deotto, L; De Riz, MA; Ferrari, E; Scarpazza, C; Fusco, ML; Ghezzi, A; Grimaldi, L; Lugaresi, A; Moiola, L; Perrone, P; Prosperini, L; Rezzonico, M; Rovaris, M; Salemi, G; Salvetti, M; Santuccio, G; Solaro, C; Tortorella, C; Capra, R
Shift from fingolimod to alemtuzumab: what happens next? 2018 Frau, J; Sacca, F; Signori, A; Baroncini, D; Fenu, G; Annovazzi, P; Capobianco, M; Signoriello, E; Laroni, A; La Gioia, S; Sartori, A; Maniscalco, GT; Bonavita, S; Clerico, M; Russo, CV; Gallo, A; Lapucci, C; Sormani, MP; Cocco, E
Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience 2017 Boffa, G; Sormani, MP; Repice, AM; Curro, D; Capobianco, M; Gualandi, F; Lo Re, M; De Gobbi, M; Innocenti, C; Capello, E; Mariottini, A; Forci, B; Uccelli, A; Barilaro, A; Cottone, S; Bertolotto, A; Saccardi, R; Mancardi, GL; Massacesi, L
Switching to alemtuzumab from fingolimod or other therapies: impact of wash-out period on disease activity 2017 Sacca, F; Sormani, MP; Signori, A; Lanzillo, R; Baroncini, D; Annovazzi, P; Signoriello, E; Laroni, A; Capobianco, M; Sartori, A; La Gioia, S; Maniscalco, G; Cordioli, C; Rasia, S; Clerico, M; Cocco, E; Frau, J